1. Pharmacy & Therapeutics Meeting
4Th Quarter P&T Committee Meeting
10000 Perkins Rowe Suite 500
Baton Rouge, LA 70810
Wayne Camp, RPh. Director of Pharmacy
November 1, 2017

2. Agenda Formulary Changes
Invega Sustenna Neomycin/polymixin/HC Susp FML Forte 0.25
Invega Trinza Modafinil tablets Pred Mild 0.12%
Risperidal Consta Armodafinil tablets Oxycodone 5mg CAPSULE
Abilify Maintena Cephalexin TABLETS Oxymorphone ER
Orenitram Morphine ER Capsule (generic Kadian)
Opsumet Suprax chew tablets Oxycontin
Avonex Mavyret Zepatier
Eliquis Ofloxacin tablets Alkeran
Tradjenta Ciprofloxacin ER tablets Vigamox
Jentadueto Ciprofloxacin 250mg/5mL Suspension
Jentadueto XR Fondaparinux Lexiva
Januvia Fragmin FOSAMPRENAVIR CALCIUM TAB 700 MG
Janumet Sprycel tablets ZIAGEN SOLUTION & TABLETS
Janumet XR Brimonidine 0.15% ophth soln ABACAVIR SOLUTION & TABLETS
BD Pen Needles Brimonidine 0.2% ophth soln COPAXONE
Non-Branded BD Pen Needles Betopic-S susp 0.25% GLATIRAMER
Timolol ophth gel FLUTICASONE – SALMETEROL AER POWDER
Moxifloxacin Betaxolol 0.5% ophth soln
Ciloxan Ointment 0.3% Carteolol 1% ophth soln
Tobrex Ointment 0.3% Levobunolol 0.5% ophth soln
Tobradex Ointent 0.3 – 0.1% Timolol 0.25% and 0.5% ophth soln
Combigan ophth soln Oxycodone concentrate solution (20mg/mL)
Tobramycin/dexamethasone Suspension %

3. Agenda Annual PA Guideline Review Summary of Changes Ampyra
Armodafinil and Modafinil
Botox
Cambi
Celecoxib
Colony Stimulating Factor
Daraprim
Erythropoiesis Stimulating Agents
GnRH Analogs
Growth Hormones
Hepatitis C
Injectable Anticoagulants
Injectable Osteoporosis
Interferons
Lyrica
Multiple Sclerosis
Non-stimulant ADHD medications
Nuedexta
Oncology Agents
Opioids (long-acting and short-acting)
Ranexa
Viscosupplements
Weight loss agents
Octreotide
Synagis
Otezla
Cytokines/CAMs